Hakami Abdullah M, Almutairi Bader, Alanazi Ahmad S, Alzahrani Mohammed A
Family Medicine, King Fahad Military Medical Complex, Dammam, SAU.
Family Medicine, Imam Abdulrahman Bin Faisal Hospital, Dammam, SAU.
Cureus. 2024 Jan 7;16(1):e51791. doi: 10.7759/cureus.51791. eCollection 2024 Jan.
Medication adherence is a critical aspect of managing type 2 diabetes mellitus (T2DM) and achieving optimal clinical outcomes. Mobile app-based interventions have emerged as a promising tool to enhance adherence and glycemic control in T2DM patients. This systematic review aims to evaluate the effectiveness of mobile app interventions in improving medication adherence and glycated hemoglobin among T2DM patients. A comprehensive search was conducted in PubMed, Cochrane Library, and Google Scholar for studies published between September 2018 and September 2023. Studies were included if they were published in English and investigated the effectiveness of mobile apps in enhancing medication adherence among patients with T2DM. Studies were excluded if they included additional interventions, such as electronic pillboxes, phone calls, or SMS text messages, or if they focused on populations with chronic illnesses other than T2DM. Five studies involving 527 participants from diverse geographic locations were included in the review. The findings from the included studies show that mobile-based app interventions can significantly improve medication adherence in patients with T2DM. From the included studies, the mean HbA1c change for the intervention group was -0.664 (95%CI -0.823 to -0.506), while the mean change in HbA1c for the control group was -0.103 (95%CI -0.305 to 0.099). Studies have demonstrated the potential of mobile app-based interventions to enhance medication adherence and improve glycemic control in T2DM; further research is needed to determine the long-term effects of these interventions.
药物依从性是管理2型糖尿病(T2DM)和实现最佳临床结果的关键方面。基于移动应用程序的干预措施已成为提高T2DM患者依从性和血糖控制的一种有前景的工具。本系统评价旨在评估移动应用程序干预对改善T2DM患者药物依从性和糖化血红蛋白的有效性。在PubMed、Cochrane图书馆和谷歌学术上进行了全面检索,以查找2018年9月至2023年9月发表的研究。如果研究以英文发表且调查了移动应用程序在提高T2DM患者药物依从性方面的有效性,则纳入研究。如果研究包括其他干预措施,如电子药盒、电话或短信,或者关注的是除T2DM以外的慢性病患者群体,则排除该研究。该评价纳入了五项研究,涉及来自不同地理位置的527名参与者。纳入研究的结果表明,基于移动应用程序的干预措施可以显著提高T2DM患者的药物依从性。在纳入的研究中,干预组的平均糖化血红蛋白变化为-0.664(95%CI -0.823至-0.506),而对照组的平均糖化血红蛋白变化为-0.103(95%CI -0.305至0.099)。研究表明,基于移动应用程序的干预措施有潜力提高T2DM患者的药物依从性并改善血糖控制;需要进一步研究来确定这些干预措施的长期效果。